SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-094871
Filing Date
2016-02-02
Accepted
2016-02-02 17:17:07
Documents
1
Period of Report
2016-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3947
  Complete submission text file 0001209191-16-094871.txt   5391
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 N. TORREY PINES RD, SUITE 125 LA JOLLA CA 92037
Business Address
REN PINGDA (Reporting) CIK: 0001635785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37620 | Film No.: 161381939